Anti-CYP3A4 Antibody

CYP3A4 (Cytochrome P450 Family 3 Subfamily A Member 4) is a key hepatic and intestinal microsomal monooxygenase responsible for the oxidative biotransformation of roughly half of all clinically prescribed pharmaceuticals. This rabbit polyclonal antibody, distributed by Antibodies.com, is raised against the human CYP3A4 enzyme and validated for Western blot, immunohistochemistry, and ELISA workflows. Supplied as 100 µl of unconjugated antiserum, the reagent enables researchers to probe CYP3A4 protein expression in human tissue samples, supporting investigations into drug metabolism, pharmacokinetics, toxicology, and personalized medicine. The polyclonal format recognises multiple epitopes on the target protein, which can be advantageous when detecting CYP3A4 variants and post-translational modifications relevant to hepatic enzyme induction and inhibition studies, as well as xenobiotic clearance research.